Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Edward A. Copelan, Betty K. Hamilton, Belinda R. Avalos, Kwang Woo Ahn, Brian J. Bolwell, Xiaochun Zhu, Mahmoud D. Aljurf, Koen W. van Besien, Christopher N. Bredeson, Jean-Yves Cahn, Luciano J. Costa, Marcos J. de Lima, Robert Peter Gale, Gregory A. Hale, Joerg Halter, Mehdi Hamadani, Yoshihiro Inamoto, Rammurti T. Kamble, Mark R. Litzow, Alison W. LorenDavid I. Marks, Eduardo Olavarria, Vivek Roy, Mitchell Sabloff, Bipin N. Savani, Matthew Seftel, Harry C. Schouten, Celalettin Ustun, Edmund K. Waller, Daniel J. Weisdorf, Baldeep M. Wirk, Mary M. Horowitz, Mukta Arora, Jeff Szer, Jorge Cortes, Matt E. Kalaycio, Richard T. Maziarz, Wael Saber

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3863-3870
JournalBlood
Volume122
Issue number24
DOIs
Publication statusPublished - 5 Dec 2013

Cite this

Copelan, E. A., Hamilton, B. K., Avalos, B. R., Ahn, K. W., Bolwell, B. J., Zhu, X., Aljurf, M. D., van Besien, K. W., Bredeson, C. N., Cahn, J-Y., Costa, L. J., de Lima, M. J., Gale, R. P., Hale, G. A., Halter, J., Hamadani, M., Inamoto, Y., Kamble, R. T., Litzow, M. R., ... Saber, W. (2013). Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood, 122(24), 3863-3870. https://doi.org/10.1182/blood-2013-07-514448